Last reviewed · How we verify
NCT03609346
Asian Registry of the BioFreedom Stent for STEMI Patients
trial testing PCI in STEMI - ST Elevation Myocardial Infarction in 914 participants. Completed in 5 August 2022.
30 January 2022
Quick facts
| Lead sponsor | Biosensors Europe SA |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 914 |
| Start date | 22 November 2018 |
| Primary completion | 30 January 2022 |
| Estimated completion | 5 August 2022 |
| Sites | 5 locations across Hong Kong, Taiwan, South Korea, Thailand, Singapore |
Drugs / interventions tested
- PCI
Conditions studied
- STEMI - ST Elevation Myocardial Infarction — all drugs for STEMI - ST Elevation Myocardial Infarction →
Sponsor
Biosensors Europe SA — full company profile →
Who can join
Eligibility, any sex, with STEMI - ST Elevation Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The BioFreedom BA9 (Stainless Steel) Drug Coated Stent is an approved stent that is already commercially available in Europe and Asia. The purpose of this registry is to assess the safety and efficacy of the BioFreedom stent for treatment of a specific group of patients; patients with a myocardial infarction (STEMI). The objective is to capture patients' outcomes and antithrombotic strategies data using one or several BioFreedom Stents in the routine treatment of these STEMI patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Polymer free biolimus coated stents to treat acute ST-elevation myocardial infarction in Asian patients.
Ong PJL, Chui SF, Tam FC, Nguyen QT, et al · · 2024 · cited 2× · PMID 39434554 · DOI 10.1002/ccd.31263
Verify or expand the search:
- PubMed search for NCT03609346
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of PCI
Trials testing the same drug.
- NCT07130188 — Predictors for ACS and Complexity of CAD · not yet recruiting
- NCT06542653 — Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion · recruiting
- NCT06050096 — DCB Treatment in CTO Guided by IVUS · unknown
- NCT06214754 — Efficacy and Safety of Intravascular High-pressure Cutting Balloon Catheters for PCI · NA · completed
- NCT05292651 — Optimal Stent Deployment Strategy of Contemporary Stents · NA · recruiting
Other recruiting trials for STEMI - ST Elevation Myocardial Infarction
Currently open trials in the same condition.
- NCT07160491 — Early Thrombolysis Guided by AI-Assisted App in Patients With STEMI · NA · recruiting
- NCT06013020 — Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus · Phase 4 · recruiting
- NCT06384846 — AI Algorithms in Prediction of ACS Based on Leukocyte Properties · recruiting
- NCT04436978 — What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI? · Phase 4 · recruiting
- NCT05800951 — Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock · active not recruiting
Other Biosensors Europe SA trials
Trials by the same sponsor.
- NCT05643430 — ULTRA LONG: BioFreedom Ultra · NA · active not recruiting
- NCT05799963 — ALPHA LONG Study- BioMatrix AlphaTM Stent Study in Patients With CAD · NA · active not recruiting
- NCT05505929 — eUltra 10k - Biofreedom Ultra · recruiting
- NCT04966273 — Study to Evaluate the Safety and Effectiveness of the Biosensors Microcatheter in Coronary Chronic Total Occlusions (CTO · NA · completed
- NCT04796038 — Rise Semi Compliant Balloon Study in Patient With CAD · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03609346 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Biosensors Europe SA
- Last refreshed: 29 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03609346.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing